Use of IMiD3, a Thalidomide Analog, as an Adjunct to Therapy for Experimental Tuberculous Meningitis
暂无分享,去创建一个
[1] G. Morgan,et al. Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma. , 2001, Blood.
[2] J. Schoeman,et al. Possible role of adjunctive thalidomide therapy in the resolution of a massive intracranial tuberculous abscess , 2001, Child's Nervous System.
[3] B. Levine,et al. New Concepts in the Immunopathogenesis of CNS Infections Edited by Phillip K. Peterson and Jack S. Remington Malden, MA: Blackwell Science, 2000. 385 pp., illustrated. $99.95 (cloth) , 2001 .
[4] K. Prasad,et al. Steroids for treating tuberculous meningitis. , 2000, The Cochrane database of systematic reviews.
[5] J. Schoeman. Thalidomide Therapy in Childhood Tuberculous Meningitis , 2000, Journal of child neurology.
[6] S. Noda,et al. [Repeated deterioration of tuberculous meningitis due to a reduction in the corticosteroid dosage during chemotherapy]. , 2000, Rinsho shinkeigaku = Clinical neurology.
[7] P. Haslett,et al. Adjunctive Thalidomide Therapy of Childhood Tuberculous Meningitis: Possible Anti-Inflammatory Role , 2000, Journal of child neurology.
[8] V. Novelli,et al. Tuberculosis of the central nervous system in children: a 20-year survey. , 2000, The Journal of infection.
[9] R. Walia,et al. Tuberculous meningitis in children: problem to be addressed effectively with thorough contact tracing , 2000, European Journal of Pediatrics.
[10] L. Casimir,et al. Tuberculous meningitis in children: clinical features and outcome in 40 cases. , 2000, Scandinavian journal of infectious diseases.
[11] J. Starke. Tuberculosis of the central nervous system in children. , 1999, Seminars in pediatric neurology.
[12] L. Corral,et al. Immunomodulation by thalidomide and thalidomide analogues , 1999, Annals of the rheumatic diseases.
[13] Nancy J. Trigg,et al. Subchronic Toxicity of Thalidomide in Rodents After 13 Weeks of Oral Administration , 1999 .
[14] P. Haslett,et al. Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. , 1999, Journal of immunology.
[15] P. Coyle. Glucocorticoids in central nervous system bacterial infection. , 1999, Archives of neurology.
[16] A. G. Gomes,et al. [Paradoxical expansive lesions of cerebral tuberculosis during antitubercular drug therapy]. , 1999, Arquivos de neuro-psiquiatria.
[17] H. Coovadia,et al. Tuberculous meningitis and co-infection with HIV. , 1998, Annals of tropical paediatrics.
[18] G. Kaplan,et al. A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death. , 1998, The Journal of infectious diseases.
[19] P. Haslett,et al. Thalidomide Costimulates Primary Human T Lymphocytes, Preferentially Inducing Proliferation, Cytokine Production, and Cytotoxic Responses in the CD8+ Subset , 1998, The Journal of experimental medicine.
[20] D. Dooley,et al. Adjunctive corticosteroid therapy for tuberculosis: a critical reappraisal of the literature. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] M. Sotir,et al. Tuberculous meningitis at a large inner-city medical center. , 1997, The American journal of the medical sciences.
[22] P. Donald,et al. Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. , 1997, Pediatrics.
[23] K. M. Murray,et al. Corticosteroids in Tuberculosis , 1996, The Annals of pharmacotherapy.
[24] V. Puri,et al. Paradoxical response to antitubercular drugs , 1995, Indian journal of pediatrics.
[25] K. Olsen,et al. Concentrations of Interferon γ, Tumor Necrosis Factor α, and Interleukin-1β in the Cerebrospinal Fluid of Children Treated for Tuberculous Meningitis , 1995 .
[26] G. Kaplan,et al. Effect of thalidomide on the inflammatory response in cerebrospinal fluid in experimental bacterial meningitis. , 1995, Microbial pathogenesis.
[27] P. Udani,et al. Pathology and pathogenetic mechanisms in neurotuberculosis. , 1995, Radiologic clinics of North America.
[28] K. Olsen,et al. Concentrations of interferon gamma, tumor necrosis factor alpha, and interleukin-1 beta in the cerebrospinal fluid of children treated for tuberculous meningitis. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] K. Viskum,et al. [Corticosteroids as adjuvants in the treatment of tuberculosis]. , 1994, Ugeskrift for laeger.
[30] K. Viskum,et al. Corticosteroids as adjuvant in the treatment of tuberculosis , 1994 .
[31] J. Fitzgerald,et al. Corticosteroids and tuberculosis: risks and use as adjunct therapy. , 1993, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[32] O. Ramilo,et al. Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation , 1990, The Journal of experimental medicine.
[33] O. Ramilo,et al. Molecular pathophysiology of bacterial meningitis: current concepts and therapeutic implications. , 1990, The Journal of pediatrics.
[34] Knut M. Wittkowski,et al. Friedman-Type Statistics and Consistent Multiple Comparisons for Unbalanced Designs with Missing Data , 1988 .
[35] S. Sulavik,et al. Resistance to Tuberculosis: Experimental Studies in Native and Acquired Defensive Mechanisms , 1966, The Yale Journal of Biology and Medicine.
[36] M. B. Lurie. CHAPTER I.NATIVE ORGAN AND SPECIES RESISTANCE TO TUBERCULOSIS: PRELIMINARY STUDIES , 1964 .
[37] A. G. Heppleston,et al. Evaluation of the method of quantitative airborne infection and its use in the study of the pathogenesis of tuberculosis. , 1950, American review of tuberculosis.
[38] Experimental Tuberculous Meningitis , 1916, The Hospital.